Imidazol derivatives as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2005231907 (hide)

Owner Merck Patent GmbH

Inventors Rosell-Vives, Elisabet; Jonczyk, Alfred; Soler Riera, Marta; Mitjans, Francesc; Stahle, Wolfgang; Adan, Jaume; Holzemann, Gunter; Rautenberg, Wilfried; Crassier, Helene; Sutter, Arne

Agent Davies Collison Cave

Pub. Number AU-A-2005231907

PCT Pub. Number WO2005/097755

Priority 10 2004 015 099.0 29.03.04 DE

Filing date 15 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 November 2006 PCT application entered the National Phase

  PCT publication WO2005/097755 Priority application(s): WO2005/097755

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005231913-Herbicidal 3-amino-2-thiomethyl benzoyl pyrazoles

2005231901-Method of operating high-pressure chamber in vacuum or low-pressure environment and observing the operation and device therefor